Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.
about
Nitric oxide synthases in heart failureIncreased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged miceOxidative Stress and Therapeutic Development in Lung DiseasesDevelopmental changes in arginase expression and activity in the lungVascular dysfunction in retinopathy-an emerging role for arginaseHypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activationMice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia.Endothelial arginine resynthesis contributes to the maintenance of vasomotor function in male diabetic mice.Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells.Piceatannol-3'-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity.Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.Amino acids, arginase and nitric oxide in vascular health.OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.TGF-β2 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells.Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase INitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cellsNitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.Recent advances in arginine metabolism: roles and regulation of the arginases.Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.Arginase Inhibition by Ethylacetate Extract of Caesalpinia sappan Lignum Contributes to Activation of Endothelial Nitric Oxide Synthase.Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury.Diabetes-induced vascular dysfunction involves arginase IEndothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.Arginase: a critical regulator of nitric oxide synthesis and vascular function.Modeling gas phase nitric oxide release in lung epithelial cells.Arginine depletion as a mechanism for the immune privilege of corneal allografts.Arginase II inhibition prevents nitrate tolerance.MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock.Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability.Arginine metabolism in vascular biology and disease.Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma.Therapeutic use of citrulline in cardiovascular disease.Role of arginase in vessel wall remodeling.Korean red ginseng inhibits arginase and contributes to endotheliumdependent vasorelaxation through endothelial nitric oxide synthase coupling.Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activity.Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.Protective Role of Arginase II in Cerebral Ischemia and Excitotoxicity.Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries.Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.
P2860
Q26830146-AD112095-A10B-42E7-AA77-F61E42086224Q28390561-6E3ACD56-8FB2-4F4A-864A-56C4EA7272B2Q28390572-51DAEE63-1CB8-4C36-A1AD-44FDF625BF6CQ28579809-BD2B446D-FE9B-4E4F-AFFC-24D46FF8C698Q33625727-C3086B31-F3D3-4D67-A2C9-BFBDB83D88B1Q33784135-6160361A-3FD5-4952-A1AA-19A77357A00CQ33840756-9FB64108-94A1-4AEB-ADDA-C7463C3AA14EQ33916398-E19C2511-9F1A-43DF-8814-E4ED6611C83DQ33934764-D7C56710-1DC3-4F6A-8C3C-29DD29591C4CQ34029838-D9285189-51DC-4C8D-9E52-6CC3F6E6537CQ34062962-A918063B-D43B-435C-BD5A-023B170A6B12Q34489450-148509EE-7C08-4067-866F-5FEE50616755Q34543359-941EC800-A804-46D0-9BF9-1AA8EE7DBD8EQ34630384-548ED941-2080-4A8B-840D-B30CB606E951Q34679092-6E171BA4-DB90-4DB2-92BF-4B80D8F1740BQ34784965-A8BCA86D-5CD6-42DF-8D76-1833774CC03AQ34934327-4C806C4E-55D2-40C6-A2FC-E43C217CCC83Q34985733-0FA50465-2057-463F-B524-76141792620CQ35050926-972818CB-457A-41C2-89CD-7BCC9B364A5FQ35158889-BBB21454-124E-4E37-BF45-6AC17A2B784EQ35855126-60E09ADC-1C15-4CC2-BACD-E96BAEDD6CD5Q35906453-34C6BA8C-14F6-449E-BAE8-A5DD334B1087Q35947546-A9D996EC-5951-4142-BF9C-6F6964406A7DQ35954810-20D088E0-98F0-4479-9206-4F34839B75DFQ36020367-2645CD64-B559-4CAB-AE31-91E965A2F782Q36043930-F6BA8774-4461-4314-B1CA-FB893E363001Q36110484-78525DE7-045A-447A-B9EB-FEC7256F2D13Q36227887-CC4C3494-34A5-49F4-9D78-4587A261CB5CQ36369969-0E9D0DE6-071A-4B15-B6DD-4431777AD0CCQ36381021-FF4B8721-9C8D-4D05-AA35-F752FF197406Q36682074-9D1CC7FE-518E-4C71-9A1B-7FE10C751F1BQ36703841-E3835B4D-2520-4A2C-B76C-9A06C91E9BF9Q36837617-BDF20361-CC5E-4E85-958B-9AE634903964Q36861288-4D66A766-5B87-4224-B396-990FE8C658BEQ36956205-931A38CD-5D41-4D2E-9CCF-B0A9FF1B7F2FQ36977685-29CFEC19-C581-4AB4-B3FB-08B39EE2A7D7Q36998882-53BD90B2-9231-442B-AA00-98FB209367E3Q37118164-B932257D-28EF-4436-8426-A89ECC4CBED6Q37230853-E9950CC6-C24C-4E8D-BC26-55B316684127Q37391969-3DF3671F-F8FC-4E82-849B-5FEF7371A04B
P2860
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Arginase inhibition increases ...... ry arterial endothelial cells.
@en
Arginase inhibition increases ...... ry arterial endothelial cells.
@nl
type
label
Arginase inhibition increases ...... ry arterial endothelial cells.
@en
Arginase inhibition increases ...... ry arterial endothelial cells.
@nl
prefLabel
Arginase inhibition increases ...... ry arterial endothelial cells.
@en
Arginase inhibition increases ...... ry arterial endothelial cells.
@nl
P2093
P2860
P1476
Arginase inhibition increases ...... ary arterial endothelial cells
@en
P2093
Leif D Nelin
Louis G Chicoine
Michael L Paffett
P2860
P356
10.1152/AJPLUNG.00194.2003
P577
2004-02-20T00:00:00Z